000 | 01836 a2200553 4500 | ||
---|---|---|---|
005 | 20250513114238.0 | ||
264 | 0 | _c19980908 | |
008 | 199809s 0 0 eng d | ||
022 | _a1098-4275 | ||
024 | 7 |
_a10.1542/peds.99.4.e2 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLeviton, A | |
245 | 0 | 0 |
_aMaternal receipt of magnesium sulfate does not seem to reduce the risk of neonatal white matter damage. _h[electronic resource] |
260 |
_bPediatrics _cApr 1997 |
||
300 |
_aE2 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAdrenal Cortex Hormones _xtherapeutic use |
650 | 0 | 4 |
_aBrain _xdrug effects |
650 | 0 | 4 |
_aCerebral Hemorrhage _xdiagnostic imaging |
650 | 0 | 4 |
_aCerebral Palsy _xdiagnostic imaging |
650 | 0 | 4 | _aConfounding Factors, Epidemiologic |
650 | 0 | 4 | _aEchoencephalography |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypertension _xdrug therapy |
650 | 0 | 4 | _aInfant, Newborn |
650 | 0 | 4 | _aInfant, Premature |
650 | 0 | 4 | _aInfant, Very Low Birth Weight |
650 | 0 | 4 |
_aLeukomalacia, Periventricular _xdiagnostic imaging |
650 | 0 | 4 | _aLogistic Models |
650 | 0 | 4 |
_aMagnesium Sulfate _xpharmacology |
650 | 0 | 4 | _aOdds Ratio |
650 | 0 | 4 |
_aPre-Eclampsia _xdrug therapy |
650 | 0 | 4 | _aPregnancy |
650 | 0 | 4 |
_aPregnancy Complications, Cardiovascular _xdrug therapy |
650 | 0 | 4 | _aProspective Studies |
700 | 1 | _aPaneth, N | |
700 | 1 | _aSusser, M | |
700 | 1 | _aReuss, M L | |
700 | 1 | _aAllred, E N | |
700 | 1 | _aKuban, K | |
700 | 1 | _aSanocka, U | |
700 | 1 | _aHegyi, T | |
700 | 1 | _aHiatt, M | |
700 | 1 | _aShahrivar, F | |
700 | 1 | _aVan Marter, L J | |
773 | 0 |
_tPediatrics _gvol. 99 _gno. 4 _gp. E2 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1542/peds.99.4.e2 _zAvailable from publisher's website |
999 |
_c9082314 _d9082314 |